![]() |
市場調查報告書
商品編碼
2133986
細胞衍生水產品市場預測至 2034 年—按水產品類型、技術、細胞來源、產品形式、分銷管道和地區進行全球分析。Cell-Based Seafood Market Forecasts to 2034 - Global Analysis By Seafood Type (Fish, Shrimp, Tuna, Salmon, Crustaceans and Other Seafood Types), Technology, Cell Source, Product Form, Distribution Channel, and Geography |
||||||
據 Stratistics MRC 稱,到 2026 年,全球細胞衍生水產品市場規模將達到 2 億美元,預計在預測期內將以 44.8% 的複合年成長率成長,到 2034 年將達到 38 億美元。
細胞衍生水產品是指透過在可控環境下培養動物細胞而非透過傳統捕撈或養殖方式獲取魚類或其他水生動物而生產的水產品。其生產過程通常包括細胞獲取、細胞培養、營養培養基、生物加工和組織形成,從而建構水產品所需的各種成分。這項技術可用於生產培養魚片、貝類、魚蛋白和水產品原料等產品。生產者的目標是在減少對野生捕撈或畜牧養殖等水產養殖系統的依賴的同時,盡可能複製傳統水產品的營養價值、質地和感官特性。其應用領域包括替代水產品、加工水產品及特殊蛋白質原料。人們對過度捕撈、海洋生態系統保護和永續蛋白質供應的日益關注正在推動這項技術的發展。細胞培養技術的進步、生物反應器效率的提升、支架材料的改進以及生產經濟效益的降低,都在推動這項技術的商業化。
市場動態
對永續水產品的需求日益成長
消費者對永續水產品的需求日益成長,這種海鮮能夠減輕對天然魚類資源的消耗和對環境的影響,從而推動了細胞衍生水產品的普及。過度捕撈和天然魚類資源的減少,使得人們迫切需要尋找替代水產品來源。人們對傳統水產品生產中存在的環境和倫理問題的認知不斷提高,也促進了市場的擴張。細胞培養技術的進步使得無需捕撈動物即可生產水產品成為可能。消費者對新型食品技術的興趣也是推動市場成長的重要因素。
生產成本高且難以擴大規模
高昂的生產成本和規模化生產的巨大挑戰限制了細胞衍生水產品的市場成長和價格競爭力。最佳化細胞培養基和生物反應器系統的技術難題影響生產的經濟效益。有限的產能和高昂的資本投入阻礙了供應。細胞衍生水產品的法規核准流程可能漫長且不確定性。消費者對細胞衍生水產品的接受度可能取決於其新穎性以及加工方法。
細胞培養和生物反應器技術的創新
細胞培養和生物反應器技術的創新為細胞衍生水產品生產商創造了巨大的成長機會。經濟高效的生產平台的開發提高了細胞衍生海鮮相對於傳統水產品的競爭力。對細胞衍生水產品研發投入的增加正在加速其商業化進程。細胞衍生水產品公司與食品生產商之間的合作正在拓展產品應用範圍。技術進步不斷提升產品品質並降低成本。
與植物來源海鮮替代品的競爭
來自植物來源海鮮替代品的競爭可能會限制細胞衍生水產品的市場成長。經濟壓力可能導致消費者優先考慮成本而非永續性。影響細胞衍生水產品標籤和核准的監管變化可能會影響市場發展。消費者對細胞衍生水產品的懷疑態度可能會影響其普及化。細胞衍生水產品的快速成長正在吸引新的進入者,並加劇競爭。
新冠感染疾病凸顯了傳統水產品供應鏈的脆弱性,並加速了人們對具有彈性生產方式的細胞衍生水產品的興趣。消費者對食品安全和永續性的日益關注推動了市場擴張。疫情後時期,對細胞衍生水產品的研發投入增加。食品體系的轉型持續推動創新。消費者對替代蛋白的認知也不斷提高。
在預測期內,魚類細分市場預計將佔據最大的市場佔有率。
預計在預測期內,魚類將佔據最大的市場佔有率。這是因為魚類是消費最廣泛、商業性價值最高的水產品類別。細胞培養魚將成為鮭魚、鮪魚和鱈魚等熱門魚種的永續替代品。對魚蛋白日益成長的需求以及對過度捕撈的擔憂正在推動其應用。成熟的魚類細胞培養技術也鞏固了該領域的主導地位。魚類是細胞培養水產品研發的重點。
在預測期內,鮭魚細分市場預計將呈現最高的複合年成長率。
在預測期內,受消費者對鮭魚的高需求以及對傳統鮭魚養殖永續性的擔憂所推動,鮭魚市場預計將呈現最高的成長率。細胞培養鮭魚提供了一種永續的替代方案,其營養價值和感官特性與傳統鮭魚不相上下。對鮭魚細胞培養技術的投資增加正在加速其商業化進程。消費者嘗試細胞培養鮭魚的意願也推動了市場成長。鮭魚是一種具有巨大市場潛力的優質水產品。
在預測期內,北美預計將佔據最大的市場佔有率,這主要得益於細胞衍生海鮮水產品的強大實力、先進的生物技術基礎設施以及對替代蛋白的早期應用。美國擁有眾多領先的細胞衍生水產品,並具備成熟的研發能力。消費者對永續性的高度關注也推動了市場擴張。食品技術投資的不斷增加進一步鞏固了該地區的市場領導地位。
在預測期內,亞太地區預計將呈現最高的複合年成長率,這主要得益於水產品消費量高、永續性意識日益增強以及對替代蛋白投資的增加。中國、日本和新加坡正在擴大其細胞衍生水產品的研發能力。對食品安全的日益關注和不斷增強的環保意識正在加速市場成長。政府對食品科技創新的支持也創造了良好的投資環境。
According to Stratistics MRC, the Global Cell-Based Seafood Market is accounted for $0.2 billion in 2026 and is expected to reach $3.8 billion by 2034 growing at a CAGR of 44.8% during the forecast period. Cell-Based Seafood consists of seafood products produced by cultivating animal cells in controlled environments rather than harvesting fish or other aquatic animals through conventional fishing or aquaculture. Production typically involves cell sourcing, cell cultivation, nutrient media, bioprocessing, and tissue structuring to develop seafood components. The technology can target products such as cultivated fish fillets, shellfish, fish proteins, and seafood ingredients. Manufacturers aim to reproduce the nutritional, textural, and sensory characteristics of conventional seafood while reducing dependence on wild catches and livestock-like aquaculture systems. Applications include alternative seafood meals, processed seafood products, and specialized protein ingredients. Growing concerns about overfishing, marine ecosystem protection, and sustainable protein supply are supporting technological development. Improvements in cell culture, bioreactor efficiency, scaffolding, and production economics are advancing commercialization.
Market Dynamics
Growing demand for sustainable seafood
Increasing consumer demand for sustainable seafood that reduces pressure on wild fish stocks and environmental impact is driving adoption of cell-based seafood. Overfishing and declining wild fish populations create urgent need for alternative seafood sources. Growing awareness of environmental and ethical issues in conventional seafood production supports market expansion. Advances in cell culture technology enable production of seafood without animal harvesting. Consumer interest in novel food technologies drives market growth.
High production costs and scale-up challenges
High production costs for cell-based seafood and significant scale-up challenges constrain market growth and price competitiveness. Technical challenges in optimizing cell culture media and bioreactor systems affect production economics. Limited production capacity and high capital requirements constrain supply availability. Regulatory approval processes for cell-based seafood can be lengthy and uncertain. Consumer acceptance of cell-based seafood may be affected by perceptions of novelty and processing.
Innovation in cell culture and bioreactor technology
Innovation in cell culture and bioreactor technology presents significant growth opportunities for cell-based seafood manufacturers. Development of cost-effective production platforms is improving competitiveness with conventional seafood. Growing investment in cell-based seafood research and development accelerates commercialization. Partnerships between cell-based seafood companies and food manufacturers expand product applications. Technology advances continue improving product quality and reducing costs.
Competition from plant-based seafood alternatives
Competition from plant-based seafood alternatives may limit market growth for cell-based seafood. Economic pressures may lead consumers to prioritize cost over sustainability. Regulatory changes affecting cell-based seafood labeling and approval may impact market development. Consumer skepticism regarding cell-based seafood may affect adoption. Rapid growth of cell-based seafood attracts new entrants and intensifies competition.
The COVID-19 pandemic highlighted vulnerabilities in conventional seafood supply chains, accelerating interest in cell-based seafood with resilient production methods. Growing consumer focus on food safety and sustainability supports market expansion. The post-pandemic period has witnessed increased investment in cell-based seafood research and development. Food system transformation continues driving innovation. Consumer awareness of alternative proteins continues growing.
The fish segment is expected to be the largest during the forecast period
The fish segment is expected to account for the largest market share during the forecast period as fish represents the most widely consumed and commercially valuable seafood category. Cell-based fish offers sustainable alternatives to popular species such as salmon, tuna, and cod. Growing demand for fish protein and concerns about overfishing drive adoption. Established cell culture technology for fish cells supports segment leadership. Fish is the primary focus of cell-based seafood development.
The salmon segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the salmon segment is predicted to witness the highest growth rate driven by high consumer demand for salmon and concerns about sustainability of conventional salmon farming. Cell-based salmon offers a sustainable alternative with comparable nutritional and sensory properties. Growing investment in salmon cell culture technology accelerates commercialization. Consumer willingness to try cell-based salmon supports market growth. Salmon is a premium seafood category with strong market potential.
During the forecast period, the North America region is expected to hold the largest market share owing to strong presence of cell-based seafood companies, advanced biotechnology infrastructure, and early adoption of alternative proteins. The United States hosts major cell-based seafood companies with established research and development capabilities. High consumer awareness of sustainability supports market expansion. Growing investment in food technology reinforces regional market leadership.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR driven by high seafood consumption, growing sustainability concerns, and increasing investment in alternative proteins. China, Japan, and Singapore are expanding cell-based seafood capabilities. Growing food security concerns and environmental awareness accelerate market growth. Government support for food technology innovation creates favorable investment environment.
Key players in the market
Some of the key players in the Cell-Based Seafood Market include BlueNalu, Inc., Wildtype Foods, Inc., Fork & Good, Inc., Avant Meats Company Limited, Umami Bioworks Pte. Ltd., Shiok Meats Pte. Ltd., Cell Base Co., Ltd., Finless Foods Inc., Revo Foods GmbH, Seafood Souq, MarineXcell, Sea & Believe, Cultured Decadence, Seafuture Sustainable Biotech, and Wildtype.
In May 2025, BlueNalu, Inc. launched a new cell-based seafood product with enhanced texture and nutritional profile. The product offers sustainable alternatives to conventional seafood. The development responds to growing demand for cell-based seafood solutions.
In April 2025, Wildtype Foods, Inc. announced significant expansion of its cell-based seafood production capacity to meet growing demand across North American markets.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.